| Product Name | MF | CAS | Details |
|---|
| 2,5-Dibromo-3-methylpyridine | C6H5Br2N | 3430-18-0 | Details |
| Resorufin | C12H7NO3 | 635-78-9 | Details |
| 3-Bromo-6-hydroxy-2-methylbenzaldehyde | C8H7BrO2 | 137644-94-1 | Details |
| tert-Butyl 2-[(4S,6R)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl]acetate | C13H22O5 | 1044518-75-3 | Details |
| tert-Butyl N-[5-(propan-2-yl)-1,3-thiazol-4-yl]carbamate | C11H18N2O2S | 1803608-32-3 | Details |
| H-KRGIVEQCCTSICSL-OH | Details |
| Ac-ACTH (1-14), 10-1-12A | C79H111N21O21S | Details |
| 2-(Pyridin-3-ylmethoxy)benzaldehyde | C13H11NO2 | 114483-63-5 | Details |
| 2-[(4-Aminophenyl)formamido]acetamide | C9H11N3O2 | 46319-19-1 | Details |
| Azithromycin | C38H72N2O12 | 83905-01-5 | Details |
| PAI1 antibody | Details |
| 1-[2-(1H-Imidazol-1-yl)pyridin-3-yl]methanamine | C9H10N4 | 954261-20-2 | Details |
| N-Tosyl-L-aspartic acid | C11H13NO6S | 4816-82-4 | Details |
| Ac-GSARAEVHLRKS-NH2 | Details |
| Sitosteryl palmitate | C45H80O2 | 2308-85-2 | Details |
| 4-Bromo-2-chlorobenzonitrile | C7H3BrClN | 154607-01-9 | Details |
| 2-Propenoic acid hydrazide hydrochlorid | C3H7ClN2O | 1707361-65-6 | Details |
| Gliadins | C29H41N7O9 | 9007-90-3 | Details |
| 6-Phenylhexan-2-one | C12H16O | 14171-89-2 | Details |
| (1-Methylcyclopropyl)methyl 2-hydroxyacetate | C7H12O3 | 1870150-09-6 | Details |
| H-LIEDNEYTAR-OH | Details |
| 1,2,3,4-Tetrahydroisoquinolin-8-ol hydrobromide | C9H12BrNO | 110192-20-6 | Details |
| Kumatakenin | C17H14O6 | 3301-49-3 | Details |
| Doxapram hydrochloride monohydrate | C24H30N2O2.ClH.H2O | 7081-53-0 | Details |
| (-)-Lycorine | C16H17NO4 | 476-28-8 | Details |
| Rat Albumin protein | Details |
| 3,4-Dibutoxybenzoic acid | C15H22O4 | 206536-14-3 | Details |
| tert-Butyl (2S)-2-(4-aminopiperidine-1-carbonyl)pyrrolidine-1-carboxylate | C15H27N3O3 | 1308650-29-4 | Details |
| 5-(Propan-2-yl)morpholin-3-one | C7H13NO2 | 119844-68-7 | Details |
| 1-[5-(Bromomethyl)-1,2-oxazol-3-yl]ethan-1-one | C6H6BrNO2 | 852107-62-1 | Details |
| (1S, 2R)-1-Phenyl-2-(1-pyrrolidinyl)-1-propanol | C13H19NO | 123620-80-4 | Details |
| NFS1 Blocking Peptide | Details |
| ((2-(dimethylamino)ethyl)amino)-N-(4-(((2-(dimethylamino)ethyl)amino)carbonylamino)phenyl)formamide | C16H28N6O2 | 1024164-18-8 | Details |
| (2-tert-Butyl-2H-1,2,3,4-tetrazol-5-yl)methanol | C6H12N4O | 1955524-36-3 | Details |
| 3-Bromoimidazo[1,2-a]pyridine-2-carbaldehyde hydrobromide | C8H5N2OBr.HBr | 1311317-97-1 | Details |
| TNFSF11 antibody (HRP) | Details |
| Epimedin B1 | C38H48O19 | 133137-58-3 | Details |
| H-AAHTEDINACTLTTSPR-OH | Details |
| 4-Methoxy-1,2-dimethylpyrrolidine-2-carboxylic acid hydrochloride | C8H16ClNO3 | 2095409-12-2 | Details |
| 3-[(Butylcarbamoyl)amino]-4-methylbenzoic acid | C13H18N2O3 | 895057-98-4 | Details |
| 5-Ethyl-1-methyl-1H-pyrazole-4-carboxylic acid | C7H10N2O2 | 1007541-96-9 | Details |
| Influenza B Virus IgG Positive Human Plasma | Details |
| (+)-O,O'-Di-p-toluoyl-D-tartaric acid | C20H18O8 | 32634-68-7 | Details |
| PDI antibody (biotin) | Details |
| 5-Chloro-3,4-dimethyl-1,2-oxazole | C5H6ClNO | 37543-60-5 | Details |
| 6-Ethyl-2-oxo-1,2,5,6,7,8-hexahydroquinoline-3-carbonitrile | C12H14N2O | 1249858-53-4 | Details |
| trans-Decahydroquinoline | C9H17N | 767-92-0 | Details |
| Recombinant RSV-F Post Fusion | Details |
| alpha-Sulfophenylacetic acid | C8H8O5S | 41360-32-1 | Details |
| Gentamicin B sulfate | C19H38N4O10 | 43169-50-2 | Details |
| 1,2,5,6-Tetrahydropyridine-2-carboxylic acid hydrochloride | C6H10ClNO2 | 41994-52-9 | Details |
| 3'-Deoxyadenosine-5'-triphosphate sodium salt - 10mM aqueous solution | C10H16N5O12P3 | 73-04-1 | Details |
| Murrayanine | C14H11NO2 | 723-97-7 | Details |
| KLHL5 Blocking Peptide | Details |
| Elacytarabine | C27H45N3O6 | 188181-42-2 | Details |
| 3-Benzyloxyaniline | C13H13NO | 1484-26-0 | Details |
| Methyl 3-amino-3-(4-fluorophenyl)propanoate | C10H12FNO2 | 181519-32-4 | Details |
| NEDD8 antibody | Details |
| 6-Hydroxy ramulosin | C10H14O4 | 29913-85-7 | Details |
| 2,2,2-Trifluoroethyl N-[2-(4-methoxyphenoxy)pyridin-3-yl]carbamate | C15H13F3N2O4 | 1221725-36-5 | Details |
| Salviaplebeiaside | C23H26O10 | 1236273-88-3 | Details |
| Ethyl piperidin-4-ylcarbamate hydrochloride | C8H17ClN2O2 | 64951-38-8 | Details |
| [1-(2-Methoxyphenyl)cyclobutyl]methanamine | C12H17NO | 927993-47-3 | Details |
| WAVE1 antibody | Details |
| 3-Bromo-2-(methoxymethyl)aniline | C8H10BrNO | 1097790-44-7 | Details |
| 3-Methyl-5-isoxazolecarbonyl chloride | C5H4ClNO2 | 49783-72-4 | Details |
| 1-(Oxan-4-yl)-2,5-dihydro-1H-pyrrole-2,5-dione | C9H11NO3 | 1153384-12-3 | Details |
| Methyl 3-(4-ethylphenyl)-1H-pyrazole-5-carboxylate | C13H14N2O2 | 1044837-18-4 | Details |
| 5-(3-Methoxypropoxy)pyrazine-2-carbonitrile | C9H11N3O2 | 1339933-49-1 | Details |
| 6-(Propan-2-yl)pyridine-3-carbonitrile | C9H10N2 | 1033750-40-1 | Details |
| Beta-Ionol | C13H22O | 22029-76-1 | Details |
| Ethyl 3,3-dimethyl-2-[(prop-2-en-1-yloxy)methyl]butanoate | C12H22O3 | 2247102-43-6 | Details |
| SARS-CoV-2 Spike S1-S2 Chimeric Antigen, Recombinant | Details |
| Epiaschantin | C22H24O7 | 41689-50-3 | Details |
| 2,2,2-Trifluoroethyl N-(3,4-dimethylphenyl)carbamate | C11H12F3NO2 | 1087797-84-9 | Details |
| 2-Bromo-3-(piperidin-1-yl)pyridine | C10H13BrN2 | 1563532-94-4 | Details |
| 8-Methyl-7-(trifluoromethyl)-1,2,3,4-tetrahydroquinoline | C11H12F3N | 1388037-17-9 | Details |
| 3-Methanesulfonyl-2,2-dimethylpropanoic acid | C6H12O4S | 5324-67-4 | Details |
| (4-Ethylhexyl)(methyl)amine hydrochloride | C9H22ClN | 1989671-33-1 | Details |
| tert-Butyl 2-(piperidin-4-yloxy)acetate hydrochloride | 162504-84-9 | Details |
| PIR-A/B antibody (allophycocyanin) | Details |
| 3-Bromobut-3-enoic acid | C4H5BrO2 | 21031-45-8 | Details |
| TACC3 Blocking Peptide | Details |
| Factor XII Antibody Pair | Details |
| H-TVAAPSVFIFPP-OH | Details |
| Pseudouridine 5'-monophosphate disodium | C9H13N2O9P | 1157-60-4 | Details |
| 6-Amino-1-(2'-deoxy-b-D-ribofuranosyl)-4-hydroxyamino-1H-pyrazolo[3,4-d]pyrimidine | Details |
| Betazole HCL | Details |
| Ethyl 5-bromo-3-(bromomethyl)-1-benzofuran-2-carboxylate | C12H10Br2O3 | 565192-82-7 | Details |
| 2-[3-(2,2,2-Trifluoroethyl)phenyl]acetic acid | C10H9F3O2 | 1369119-16-3 | Details |
| tert-Butyl 3-amino-4H,5H,6H,7H-[1,2]oxazolo[4,3-c]pyridine-5-carboxylate | C11H17N3O3 | 1503686-08-5 | Details |
| OR6C2 antibody | Details |
| Methyl 5-(bromomethyl)-2-furoate | C7H7BrO3 | 70117-25-8 | Details |
| 2-(6-Nitro-2-oxo-2,3-dihydro-1,3-benzoxazol-3-yl)acetic acid | C9H6N2O6 | 19739-41-4 | Details |
| Tert-Butyl 3-Iodo-1H-Pyrrolo[3,2-C]Pyridine-1-Carboxylate | C12H13IN2O2 | 877060-48-5 | Details |
| (3S, 4R) -Dihydro- 3-hydroxy- 3- methyl-4-tert butyldimethylsilyloxy- 2(3H) - furanone | Details |
| {1-Methyl-1-azaspiro[3.3]heptan-6-yl}methanamine | C8H16N2 | 2375262-54-5 | Details |
| H-QPRYPVNSV-OH | Details |
| Polyethylene glycol 12-hydroxystearate | C20H40O4 | 61909-81-7 | Details |
| Trijuganone C | C20H20O5 | 135247-94-8 | Details |
| Product Total： Product Page： | ||||
| 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 | ||||